Horseradish peroxidase-dependent oxidation of deuteroporphyrin IX into chlorins.
Chlorins are cyclic tetrapyrrole derivatives of great interest for use in photodynamic therapy. We have found that horseradish peroxidase (EC 1.11.1.7) (HRP) can convert deuteroporphyrin IX (Deutero) into chlorins. Some characteristics of this enzymatic transformation were investigated. The formation of chlorins was determined spectrophotometrically by monitoring the change in absorbance in the Q-band region (638 nm). The reaction occurred without addition of H2O2 and had a pH optimum of 7.5. The presence of thiol-containing reductants, with a great preference for reduced glutathione, was required and could not be substituted by adding H2O2. Ascorbic acid acted as a potent inhibitor of the reaction, while other organic acids (citric and benzoic) had little to no inhibitory effect. The requirement for O2 was suggested by the inhibitory effect of sodium hydrosulfite and was confirmed by carrying the assay in nitrogen-saturated solutions. Though the reaction occurred without adding H2O2, low amounts of H2O2 (3-30 microM) were stimulatory to the assay. However, concentrations of 300 microM H2O2 or higher were inhibitory. Similarly, light was not required, but was stimulatory at low levels and inhibitory at high levels. Catalase and deferoxamine were inhibitory, but superoxide dismutase and mannitol had no effects. Kinetic analysis and respiratory studies suggest that HRP may initially react with reduced glutathione in a reaction that does not consume much oxygen. The ensuing steps, probably involving an oxygen free radical and porphyrin radical intermediates, consume a large amount of O2 to oxidize Deutero into chlorin.
Dayan
F E
FE
USDA/ARS/NPURU, National Center for the Development of Natural Products, School of Pharmacy, University of Mississippi, 38677, USA. fdayan@ag.gov
Duke
S O
SO
Faibis
V
V
Jacobs
J M
JM
Jacobs
N J
NJ
D001205:Ascorbic Acid / Q000494:pharmacology; D002374:Catalase / Q000494:pharmacology; D003676:Deferoxamine / Q000494:pharmacology; D003905:Deuteroporphyrins / Q000378:metabolism*; D004492:Edetic Acid / Q000494:pharmacology; D005978:Glutathione / Q000378:metabolism; D006735:Horseradish Peroxidase / Q000378:metabolism*; D006861:Hydrogen Peroxide / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D010084:Oxidation-Reduction; D010100:Oxygen / Q000494:pharmacology; D017319:Photosensitizing Agents / Q000378:metabolism*; D011166:Porphyrins / Q000378:metabolism*; D013056:Spectrophotometry, Ultraviolet; D013438:Sulfhydryl Compounds / Q000494:pharmacology
D003905:Deuteroporphyrins; D017319:Photosensitizing Agents; D011166:Porphyrins; D013438:Sulfhydryl Compounds; C006969:chlorin; C028839:deuteroporphyrin-IX; D004492:Edetic Acid; D006861:Hydrogen Peroxide; D006735:Horseradish Peroxidase; D002374:Catalase; D005978:Glutathione; D003676:Deferoxamine; D001205:Ascorbic Acid; D010100:Oxygen